These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Role of octreotide in the treatment of hypoglycemia induced by sulfonylureas]. Clerc D, Hugli O, Trueb L, Yersin B. Rev Med Suisse; 2008 Aug 20; 4(167):1764-7. PubMed ID: 18800755 [Abstract] [Full Text] [Related]
8. [Adverse effects and interactions of oral antidiabetics]. Czyzyk A, Stryjek-Kamińska D. Pol Tyg Lek; 1980 Nov 10; 35(45):1757-60. PubMed ID: 7012809 [No Abstract] [Full Text] [Related]
9. [Oral antidiabetic agents: what are the choices?]. Crausaz FM. Rev Med Suisse Romande; 1991 Aug 10; 111(8):701-5. PubMed ID: 1925244 [No Abstract] [Full Text] [Related]
10. Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide. Borst GC. J Ky Med Assoc; 1988 Mar 10; 86(3):129-30. PubMed ID: 3356924 [No Abstract] [Full Text] [Related]
11. Adverse drug reaction: a possible case of glimepiride-induced syndrome of inappropriate antidiuretic hormone secretion. Adachi H, Yanai H. Diabetes Metab; 2015 Apr 10; 41(2):176-7. PubMed ID: 25559655 [No Abstract] [Full Text] [Related]
12. [Severe hypoglycemia due to insulin. Risks and adverse effects of antidiabetic drugs]. Auzepy P, Caquet R. Sem Hop; 1983 Mar 10; 59(10):697-705. PubMed ID: 6304892 [No Abstract] [Full Text] [Related]
13. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment. Harrigan RA, Nathan MS, Beattie P. Ann Emerg Med; 2001 Jul 10; 38(1):68-78. PubMed ID: 11423816 [Abstract] [Full Text] [Related]
14. Predictors of relapse in elderly diabetic patients admitted with sulphonylurea-induced severe hypoglycaemic attacks. Chan TY, Cheung AY. Age Ageing; 1997 Sep 10; 26(5):409-10. PubMed ID: 9351488 [No Abstract] [Full Text] [Related]
15. Oral hypoglycemic agents in type II diabetes mellitus. Lubbos H, Miller JL, Rose LI. Am Fam Physician; 1995 Nov 15; 52(7):2075-8. PubMed ID: 7484707 [Abstract] [Full Text] [Related]
16. Emergency management of oral hypoglycemic drug toxicity. Rowden AK, Fasano CJ. Emerg Med Clin North Am; 2007 May 15; 25(2):347-56; abstract viii. PubMed ID: 17482024 [Abstract] [Full Text] [Related]
17. [The risk of hypoglycemia in sulfonylurea therapy]. Berger W, Koller F. Helv Med Acta; 1972 Apr 15; 36(2):228-9. PubMed ID: 5029101 [No Abstract] [Full Text] [Related]
18. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides. Mannucci E, Monami M, Masotti G, Marchionni N. Diabetes Metab Res Rev; 2004 Apr 15; 20(1):44-7. PubMed ID: 14737744 [Abstract] [Full Text] [Related]
19. [Complications in the therapy of diabetes using oral hypoglycemic agents]. De Luca E, Pellegrini M. Minerva Med; 1974 Dec 15; 65(90):4769-71. PubMed ID: 4449610 [No Abstract] [Full Text] [Related]
20. [Oral antidiabetics]. Bäbler M. Schweiz Rundsch Med Prax; 1972 Feb 22; 61(8):242-6. PubMed ID: 4659095 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]